Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-19-004543
Filing Date
2019-04-01
Accepted
2019-04-01 16:37:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 120394
  Complete submission text file 0001493152-19-004543.txt   122091
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Subject) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-77935 | Film No.: 19721202
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578
Business Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578 208-263-6695
10X Fund, L.P. (Filed by) CIK: 0001453356 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A